Stryker is one of the world's leading medical technology companies, offering innovative products and services that help improve patient and hospital outcomes. The COVID-19 pandemic has led to severe disruptions in the market and has materially adversely affected operations and financial results. The response to the pandemic included unprecedented measures that have significantly impacted Stryker's operations, including the postponement of elective medical procedures. In 2020, reported net sales declined 3.6%, and the company continued its capital allocation strategy by investing in acquisitions and paying dividends to shareholders. Research, development, and engineering expenses increased as the company focused on developing new products and integrating recent acquisitions. Selling, general, and administrative expenses included charges related to a new global ERP system that was in process of being developed for future deployment. The postponement of elective procedures due to the pandemic negatively affected unit volumes, particularly in orthopaedics and neurotechnology segments. The company’s operational flexibility and ability to adapt to market dynamics are critical as it navigates the ongoing challenges posed by the pandemic. Stryker's IT capabilities are integral to supporting business needs and enhancing operational efficiency, as evidenced by the focus on integrating technology resources and managing information effectively. The firm’s ability to mobilize and deploy IT-based resources in combination with leveraging other capabilities is essential in transforming Stryker into a competitive force. The company’s financial condition reflects its capacity to generate substantial cash from operations and access capital markets, which is crucial for funding acquisitions and maintaining operational needs. The strategic management practices employed by Stryker emphasize the importance of information management capabilities, including providing data and information with appropriate levels of accuracy, timeliness, and reliability. The integration of technology into business processes is vital for achieving market agility and responsiveness to consumer demands. The firm’s investments in digital technologies and innovation partnerships are aimed at enhancing its competitive positioning and driving future growth. The ongoing evaluation of strategic resource allocation and investment choices will determine Stryker's ability to navigate the evolving healthcare landscape and maintain its market leadership. The company’s commitment to operational excellence and performance improvement is reflected in its focus on research and development, which is essential for sustaining its competitive advantage in the medical technology sector.